TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Dating Sites: Best, Worst & Weirdest
OPINION

5 stocks under $10 set to soar

  • By Roberto Pedone
  • Mar 31, 2016 8:44 AM EDT
CBOE Stock Slumps, Buying Bats Global Markets for $3.2 Billion
MARKETS

Transition Therapeutics (TTHI) Stock Climbs on Positive Alzheimer Treatment Data

  • By Tony Owusu
  • Oct 15, 2015 3:16 PM EDT
Amkor (AMKR) Stock Spikes on Q2 Beat, Outlook
OPINION

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Aug 13, 2015 10:53 AM EDT
5 Heavily Shorted Stocks Set to Soar on Bullish Earnings
INVESTING

2 Biotech Stocks Under $10 Triggering Breakouts

  • By Roberto Pedone
  • Nov 13, 2013 7:00 AM EST
5 Bargain Bin Stocks to Buy in March
INVESTING

5 Stocks Under $10 to Trade for Breakouts

  • By Roberto Pedone
  • Oct 18, 2013 8:15 AM EDT
5 Stocks Set to Soar on Bullish Earnings
INVESTING

4 Stocks Under $10 in Breakout Territory

  • By Roberto Pedone
  • Oct 9, 2013 8:35 AM EDT
4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More
INVESTING

5 Biotech Stocks Under $10 on the Move

  • By Roberto Pedone
  • Sep 20, 2013 8:39 AM EDT
Oracle Rises to the Cloud, While Jabil Goes to the Woodshed
MARKETS

5 Stocks Under $5 Making Big Moves

  • By Roberto Pedone
  • Sep 20, 2012 2:30 PM EDT
Oracle Rises to the Cloud, While Jabil Goes to the Woodshed
MARKETS

7 Stocks Under $10 With Relative Strength

  • By Roberto Pedone
  • Jul 6, 2012 2:27 PM EDT
Hedge Funds Love These 5 Consumer Stocks -- but Should You?
INVESTING

5 Stocks With Huge Insider Buying

  • By Roberto Pedone
  • Dec 1, 2011 6:12 AM EST
Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

Transition Therapeutics Inc. Stock Downgraded (TTHI)

  • By TheStreet Wire
  • May 23, 2011 8:40 AM EDT
Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

Transition Stock Gaps Up On Today's Open (TTHI)

  • By TheStreet Wire
  • Mar 21, 2011 9:56 AM EDT
Insider Trading Alert - RYL, BHB And AAL Traded By Insiders
MARKETS

Transition Stock Soars Higher (TTHI)

  • By TheStreet Wire
  • Feb 22, 2011 10:11 AM EST
Insider Trading Alert - UVE, WETF And ENPH Traded By Insiders
MARKETS

Transition Therapeutics Inc. Stock Upgraded By TheStreet Ratings (TTHI)

  • By TheStreet Wire
  • Feb 9, 2011 5:31 PM EST
Alkermes, Arena: Volume Movers
INVESTING

Alkermes, Arena: Volume Movers

  • By Robert Holmes
  • Sep 17, 2010 7:49 AM EDT
Neurocrine Licenses Drug to Abbott:BioBuzz
STOCKS

10 Alzheimer's Disease Treatment Stocks

  • By Adam Feuerstein
  • Aug 18, 2010 6:00 AM EDT
Abbott Goes After Endometriosis
STOCKS

Transition Therapeutics to Pay Eli Lilly $1M

  • By Andrea Tse
  • Mar 3, 2010 9:17 AM EST
Dating Sites: Best, Worst & Weirdest
STOCKS

CardioNet, Cyclacel: Midday Volume Plays

  • By Robert Holmes
  • Dec 15, 2009 2:29 PM EST
A Letter to Cel-Sci's Geert and Max
STOCKS

Safety Dogs Elan Alzheimer's Drug; Seattle Genetics Finds New Partner: BioBuzz

  • By Adam Feuerstein
  • Dec 15, 2009 6:00 AM EST
STOCKS

Biotech Mailbag: Biocryst, Anadys, Allos, Amag

  • By Adam Feuerstein
  • Aug 21, 2009 7:00 AM EDT
Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

Biotech Stock Mailbag: Chelsea Therapeutics

  • By Adam Feuerstein
  • Jul 10, 2009 8:00 AM EDT
Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal
STOCKS

Biotech Calendar: Key Clinical Trial Dates

  • By Adam Feuerstein
  • Jun 10, 2009 11:02 AM EDT
Karyopharm Sees Quicker U.S. Approval Path for Multiple Myeloma Drug
STOCKS

Genentech Studies How Alzheimer's Attacks Brain

  • By Adam Feuerstein
  • Feb 19, 2009 12:11 AM EST
Dating Sites: Best, Worst & Weirdest
INVESTING

Health Winners & Losers: Biogen

  • By Elizabeth Trotta
  • Aug 1, 2008 5:06 PM EDT
STOCKS

Alzheimer's Drug Stocks May Be Worth Wait

  • By Adam Feuerstein
  • Oct 10, 2007 12:38 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.